APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,895,605 | -72.1% | 76,120 | -33.1% | 0.10% | -67.7% |
| Q2 2023 | $10,364,903 | -3.9% | 113,775 | -30.4% | 0.32% | -2.7% |
| Q1 2023 | $10,781,228 | +14.2% | 163,451 | -10.4% | 0.33% | +13.5% |
| Q4 2022 | $9,437,489 | +1.1% | 182,508 | +33.5% | 0.29% | -5.2% |
| Q3 2022 | $9,339,000 | +45.9% | 136,735 | -3.4% | 0.30% | +39.3% |
| Q2 2022 | $6,403,000 | -18.1% | 141,592 | -8.0% | 0.22% | +12.9% |
| Q1 2022 | $7,821,000 | +97.8% | 153,923 | +84.1% | 0.19% | +139.5% |
| Q4 2021 | $3,953,000 | – | 83,601 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |